These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 1855772

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Carcinoma of the ampulla of Vater: expression of cancer-associated antigens inversely correlated with prognosis.
    Kamisawa T, Fukayama M, Koike M, Tabata I, Egawa N, Isawa T, Okamoto A, Hayashi Y.
    Am J Gastroenterol; 1988 Oct; 83(10):1118-23. PubMed ID: 3048082
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Basic and clinical evaluation of measurement of pancreatic cancer associated antigen, SPan-1].
    Chung YS, Nakata B, Tanaka H, Kubo T, Satake K, Sowa M, Umeyama K.
    Nihon Geka Gakkai Zasshi; 1990 Feb; 91(2):228-33. PubMed ID: 2325607
    [Abstract] [Full Text] [Related]

  • 11. Tumor markers in pancreatic cancer. Sensitivity and specificity of CA 19-9.
    Safi F, Roscher R, Beger HG.
    Hepatogastroenterology; 1989 Dec; 36(6):419-23. PubMed ID: 2613165
    [Abstract] [Full Text] [Related]

  • 12. [Clinical significance of pancreatic oncofetal antigen, pancreatic cancer associated antigen assay as tumor markers].
    Shimano T, Morimoto H, Saito M, Mori T.
    Nihon Rinsho; 1990 Feb; 48 Suppl():917-9. PubMed ID: 2192174
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Pancreatic oncofetal antigen (POA) and carcinoma of the pancreas].
    Homma T, Oguchi H, Kawa S, Nagata A, Furuta S.
    Gan No Rinsho; 1984 May; 30(6 Suppl):558-62. PubMed ID: 6205174
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Pancreatic cancer-associated new carbohydrate antigen].
    Yuan M.
    Zhonghua Zhong Liu Za Zhi; 1987 May; 9(3):183-6, 11. PubMed ID: 2452061
    [Abstract] [Full Text] [Related]

  • 19. [Monoclonal antibody SPan-1 in the diagnosis of exocrine pancreatic adenocarcinoma].
    Frena A, Mazziotti A, La Guardia G, Martin F.
    Chir Ital; 2000 May; 52(4):369-77. PubMed ID: 11190527
    [Abstract] [Full Text] [Related]

  • 20. Serum CA 242 in pancreatic cancer. Comparison with CA 19-9 and CEA.
    Pezzilli R, Billi P, Plate L, Laudadio MA, Sprovieri G.
    Ital J Gastroenterol; 1995 May; 27(6):296-9. PubMed ID: 8562994
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.